Researchers have identified a novel Parkinson’s disease drug target and a compound capable of repairing neurons derived from Parkinson’s patients.
A gene mutation which causes Lesch-Nyhan syndrome could provide clues to the developmental and neurological defects noted in other neurodegenerative diseases.
Researchers have identified a possible molecular pathway which could be the of cause a number of neurodegenerative diseases, including Huntington’s disease and ALS.
Researchers have developed a new way in which to measure the shape of the huntingtin protein in living cells.
A new study indicates that quickly clearing away defective proteins in the brain could help prevent some neurodegenerative disorders.
Using sophisticated imaging techniques, researchers observe a molecular protein folding process which could help better understand and treat neurodegenerative diseases and cancers.
A new study shows that the GLT1 protein plays a critical role in the craving for cocaine which develops after only a few days of cocaine use. However, exposure to ceftriaxone, an antibiotic used to treat meningitis, decreases cocaine cravings.
Researchers mobilize the brain’s native stem cells to replenish medium spiny neurons which are lost in Huntington’s disease.
Researchers discover a three molecule complex could be a target for treating Huntington’s Disease, a genetic and currently incurable brain disease which causes movement disorders and dementia.
Voluntary movements involve the coordinated activation of two brain pathways that connect parts of deep brain structures called the basal ganglia, according to a study in mice.